AVITA Medical Statistics
Total Valuation
AVITA Medical has a market cap or net worth of $342.30 million. The enterprise value is $343.52 million.
Important Dates
The last earnings date was Thursday, November 7, 2024, after market close.
| Earnings Date | Nov 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
AVITA Medical has 26.23 million shares outstanding. The number of shares has increased by 1.92% in one year.
| Current Share Class | 26.23M |
| Shares Outstanding | 26.23M |
| Shares Change (YoY) | +1.92% |
| Shares Change (QoQ) | +0.87% |
| Owned by Insiders (%) | 1.75% |
| Owned by Institutions (%) | 23.95% |
| Float | 25.68M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 5.59 |
| Forward PS | 3.52 |
| PB Ratio | 27.98 |
| P/TBV Ratio | 29.41 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 5.72 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.73, with a Debt / Equity ratio of 3.73.
| Current Ratio | 3.73 |
| Quick Ratio | 3.21 |
| Debt / Equity | 3.73 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -11.34 |
Financial Efficiency
Return on equity (ROE) is -152.44% and return on invested capital (ROIC) is -59.50%.
| Return on Equity (ROE) | -152.44% |
| Return on Assets (ROA) | -45.37% |
| Return on Capital (ROIC) | -59.50% |
| Revenue Per Employee | $290,048 |
| Profits Per Employee | -$276,913 |
| Employee Count | 207 |
| Asset Turnover | 0.74 |
| Inventory Turnover | 1.62 |
Taxes
In the past 12 months, AVITA Medical has paid $47,000 in taxes.
| Income Tax | 47,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +3.57% in the last 52 weeks. The beta is 1.54, so AVITA Medical's price volatility has been higher than the market average.
| Beta (5Y) | 1.54 |
| 52-Week Price Change | +3.57% |
| 50-Day Moving Average | 10.92 |
| 200-Day Moving Average | 11.11 |
| Relative Strength Index (RSI) | 67.08 |
| Average Volume (20 Days) | 112,864 |
Short Selling Information
| Short Interest | 1.19M |
| Short Previous Month | 1.34M |
| Short % of Shares Out | 4.62% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 18.05 |
Income Statement
In the last 12 months, AVITA Medical had revenue of $60.04 million and -$57.32 million in losses. Loss per share was -$2.23.
| Revenue | 60.04M |
| Gross Profit | 51.43M |
| Operating Income | -58.82M |
| Pretax Income | -49.74M |
| Net Income | -57.32M |
| EBITDA | -57.92M |
| EBIT | -58.82M |
| Loss Per Share | -$2.23 |
Full Income StatementBalance Sheet
The company has $44.41 million in cash and $45.63 million in debt, giving a net cash position of -$1.22 million or -$0.05 per share.
| Cash & Cash Equivalents | 44.41M |
| Total Debt | 45.63M |
| Net Cash | -1.22M |
| Net Cash Per Share | -$0.05 |
| Equity (Book Value) | 12.23M |
| Book Value Per Share | 0.47 |
| Working Capital | 46.78M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$51.72 million and capital expenditures -$7.86 million, giving a free cash flow of -$59.58 million.
| Operating Cash Flow | -51.72M |
| Capital Expenditures | -7.86M |
| Free Cash Flow | -59.58M |
| FCF Per Share | -$2.27 |
Full Cash Flow StatementMargins
Gross margin is 85.66%, with operating and profit margins of -97.97% and -95.47%.
| Gross Margin | 85.66% |
| Operating Margin | -97.97% |
| Pretax Margin | -95.39% |
| Profit Margin | -95.47% |
| EBITDA Margin | -96.47% |
| EBIT Margin | -97.97% |
| FCF Margin | -106.74% |
Dividends & Yields
AVITA Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.92% |
| Shareholder Yield | -1.92% |
| Earnings Yield | -16.75% |
| FCF Yield | -17.40% |
Analyst Forecast
The average price target for AVITA Medical is $16.50, which is 26.44% higher than the current price. The consensus rating is "Hold".
| Price Target | $16.50 |
| Price Target Difference | 26.44% |
| Analyst Consensus | Hold |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 28.85% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
The last stock split was on June 30, 2020. It was a reverse split with a ratio of 0.2:1.
| Last Split Date | Jun 30, 2020 |
| Split Type | Reverse |
| Split Ratio | 0.2:1 |
Scores
AVITA Medical has an Altman Z-Score of -4.37 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -4.37 |
| Piotroski F-Score | 3 |